{"url": "https://www.statnews.com/2016/12/08/biogen-lilly-alzheimers/", "text": "Why Biogen is breathing a sigh of relief with the latest Alzheimer\u2019s data\n\nWe already know Eli Lilly\u2019s big bet on Alzheimer\u2019s disease didn\u2019t work. But a deep dive into just how it failed has provided a bit of encouragement to Biogen (BIIB) and the many companies still hoping to succeed where their rival fell short.\n\nLilly\u2019s treatment, solanezumab, had no significant effect on the buildup of toxic brain plaques believed by many to be responsible for Alzheimer\u2019s neuron-destroying effects. The company had already disclosed that the treatment failed to improve patients\u2019 cognition and function, but the new data, released Thursday night, shed some important light on the underlying biology.", "images": ["https://www.statnews.com/wp-content/uploads/2018/03/Circular_Damian.png", "https://www.statnews.com/wp-content/uploads/2019/08/Newsletter-Logo-Images-DR.png", "https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg", "https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/330x400-00000000.png", "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-645x645.jpg", "https://dc.ads.linkedin.com/collect/?pid=46858&fmt=gif", "https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg", "https://www.facebook.com/tr?id=436331036555416&ev=PageView&noscript=1", "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-1024x576.jpg"], "top_img": "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-1024x576.jpg", "keywords": [], "authors": ["Damian Garde", "Adam Feuerstein", "Sharon Begley", "Ed Silverman"], "canonical_link": "https://www.statnews.com/2016/12/08/biogen-lilly-alzheimers/", "title": "Why Biogen is breathing a sigh of relief with the latest Alzheimer\u2019s data", "meta_data": {"viewport": "width=device-width, initial-scale=1", "referrer": "origin", "description": "New data on Eli Lilly\u2019s failed Alzheimer\u2019s drug offers hope to Biogen and the many companies still hoping to succeed where their rival fell short.", "og": {"locale": "en_US", "type": "article", "title": "Why Biogen is breathing a sigh of relief with the latest Alzheimer's data", "description": "New data on Eli Lilly\u2019s failed Alzheimer\u2019s drug offers hope to Biogen and the many companies still hoping to succeed where their rival fell short.", "url": "https://www.statnews.com/2016/12/08/biogen-lilly-alzheimers/", "site_name": "STAT", "updated_time": "2016-12-09T15:33:14+00:00", "image": {"identifier": "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-1024x576.jpg", "secure_url": "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-1024x576.jpg", "width": 1024, "height": 576}}, "article": {"publisher": "http://facebook.com/statnews/", "tag": "pharmaceuticals", "section": "Biotech", "published_time": "2016-12-09T02:45:46+00:00", "modified_time": "2016-12-09T15:33:14+00:00"}, "fb": {"app_id": 933808010032702, "pages": 1456948254627841}, "twitter": {"card": "summary_large_image", "description": "New data on Eli Lilly\u2019s failed Alzheimer\u2019s drug offers hope to Biogen and the many companies still hoping to succeed where their rival fell short.", "title": "Why Biogen is breathing a sigh of relief with the latest Alzheimer's data", "site": "@statnews", "image": "https://www.statnews.com/wp-content/uploads/2015/11/Biogen-sign_AP-mage-1024x576.jpg", "creator": "@damiangarde"}, "generator": "WordPress 5.2.4", "apple-itunes-app": "app-id=1324796990", "msapplication-TileImage": "https://www.statnews.com/wp-content/uploads/2015/10/cropped-stat-logo-teal-328x328.png"}, "movies": [], "publish_date": 1481173200.0, "source": "https://www.statnews.com", "summary": ""}